|
1
|
Kamangar F, Dores GM and Anderson WF:
Patterns of cancer incidence, mortality and prevalence across five
continents: Defining priorities to reduce cancer disparities in
different geographic regions of the world. J Clin Oncol.
24:2137–2150. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lin DX, Tan W, Lu SX, et al: Molecular
epidemiological study of Chinese esophageal cancer. Chin J
Epidemiology. 10:130–135. 2003.(In Chinese).
|
|
4
|
Lu XM, Zhang YM, Lin RY, Arzi G, Wang X,
Zhang YL, Zhang Y, Wang Y and Wen H: Relationship between genetic
polymorphisms of metabolizing enzymes CYP2E1, GSTM1 and Kazakh's
esophageal squamous cell cancer in Xinjiang, China. World J
Gastroenterol. 11:3651–3654. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bazley LA and Gullick WJ: The epidermal
growth factor receptor family. Endocr Relat Cancer. 12(Suppl 1):
S17–S27. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Andl CD, Mizushima T, Nakagawa H, Oyama K,
Harada H, Chruma K, Herlyn M and Rustgi AK: Epidermal growth factor
receptor mediates increased cell proliferation, migration and
aggregation in esophageal keratinocytes in vitro and in vivo. J
Biol Chem. 278:1824–1830. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hanawa M, Suzuki S, Dobashi Y, Yamane T,
Kono K, Enomoto N and Ooi A: EGFR protein overexpression and gene
amplification in squamous cell carcinomas of the esophagus. Int J
Cancer. 118:1173–1180. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang RG, Zang GQ, Feng J, et al:
Expression of c-Myb, VEGFR and EGFR protein in human hepatic
cirrhosis and hepatocellular carcinoma tissues. Chin J
Gastroenterol Hapatol. 16:420–423. 2007.(In Chinese).
|
|
9
|
Brand TM, Iida M and Wheeler DL: Molecular
mechanisms of resistance to the EGFR monoclonal antibody cetuximab.
Cancer Biol Ther. 11:777–792. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu X, Hedman H, Bergqvist M, Bergström S,
Henriksson R, Gullbo J, Lennartsson J, Hesselius P and Ekman S:
Expression of EGFR and LRIG proteins in oesophageal carcinoma with
emphasis on patient survival and cellular chemosensitivity. Acta
Oncol. 51:69–76. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kii T, Takiuchi H, Kawabe S, Gotoh M, Ohta
S, Tanaka T, Kuwakado S, Nishitani H and Katsu K: Evaluation of
prognostic factors of esophageal squamous cell carcinoma (stage
II-III) after concurrent chemoradiotherapy using biopsy specimens.
Jpn J Clin Oncol. 37:583–589. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang F, Tang X, Riquelme E, Behrens C,
Nilsson MB, Giri U, Varella-Garcia M, Byers LA, Lin HY, Wang J, et
al: Increased VEGFR-2 gene copy is associated with chemoresistance
and shorter survival in patients with non-small-cell lung carcinoma
who receive adjuvant chemotherapy. Cancer Res. 71:5512–5521. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rodríguez-Antona C, Pallares J,
Montero-Conde C, Inglada-Pérez L, Castelblanco E, Landa I, Leskelä
S, Leandro-García LJ, López-Jiménez E, Letón R, et al:
Overexpression and activation of EGFR and VEGFR2 in medullary
thyroid carcinomas is related to metastasis. Endocr Relat Cancer.
17:7–16. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Edge SB, Byrd DR, Compton CC, et al:
Esophageal and esophagogastric junction. AJCC Cancer Staging Manual
(7th). (New York, NY). Springer. 103–115. 2010.
|
|
15
|
Gibault L, Metges JP, Conan-Charlet V,
Lozac'h P, Robaszkiewicz M, Bessaguet C, Lagarde N and Volant A:
Diffuse EGFR staining is associated with reduced overall survival
in locally advanced oesophageal squamous cell cancer. Br J Cancer.
93:107–115. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mimura K, Kono K, Maruyama T, Watanabe M,
Izawa S, Shiba S, Mizukami Y, Kawaguchi Y, Inoue M, Kono T, et al:
Lapatinib inhibits receptor phosphorylation and cell growth and
enhances antibody-dependent cellular cytotoxicity of EGFR- and
HER2-overexpressing esophageal cancer cell lines. Int J Cancer.
129:2408–2416. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ajani JA, D'Amico TA, Almhanna K, Bentrem
DJ, Besh S, Chao J, Das P, Denlinger C, Fanta P, Fuchs CS, et al:
Esophageal and esophagogastric junction cancers, version 1.2015. J
Natl Compr Canc Netw. 13:194–227. 2015.PubMed/NCBI
|
|
18
|
Zhang Q, Yu C, Peng S, Xu H, Wright E,
Zhang X, Huo X, Cheng E, Pham TH, Asanuma K, et al: Autocrine VEGF
signaling promotes proliferation of neoplastic Barrett's epithelial
cells through a PLC-dependent pathway. Gastroenterology.
146:461–472. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pei XJ, Yang QX and Zou DM: Preliminary
study in Huizhou Hakka population of esophageal cancer EGFR protein
expression and correlation with MAPK signaling pathway. China
Medical Herald. 9:16–19. 2012.
|
|
20
|
Carneiro A, Isinger A, Karlsson A,
Johansson J, Jönsson G, Bendahl PO, Falkenback D, Halvarsson B and
Nilbert M: Prognostic impact of array-based genomic profiles in
esophageal squamous cell cancer. BMC Cancer. 8:982008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kaneko K, Kumekawa Y, Makino R, Nozawa H,
Hirayama Y, Kogo M, Konishi K, Katagiri A, Kubota Y, Muramoto T, et
al: EGFR gene alterations as a prognostic biomarker in advanced
esophageal squamous cell carcinoma. Front Biosci (Landmark Ed).
15:65–72. 2010. View
Article : Google Scholar : PubMed/NCBI
|
